Ainslie Forbes

Executive Director, Head of Digital Health R&D

Throughout the last ten years, Ainslie has been committed to the development of digital health solutions to address unmet medical needs. As Head of Digital Health R&D at Otsuka Pharmaceutical Development and Commercialization, Inc, Ainslie provides R&D leadership for the digital health portfolio and initiatives including digital therapeutic, digital medicine and digital biomarkers. She is a key contributor in defining Otsuka’s digital health strategy and leads efforts to create new digital health processes for evidence generation. Earlier in her career, Ainslie worked in various development and medical roles across various psychiatric disease states including major depressive disorder, schizophrenia, and bipolar disorder. Prior to this, she trained as a clinical psychologist and practiced cognitive-behavior therapy and other evidence-based psychotherapies in a variety of disease states. Ainslie earned her Bachelor’s Degree in psychology before completing her Doctorate of Clinical Psychology (D.Clin.Psych), followed by an additional graduate program to receive Doctor of Philosophy (Ph.D.) in cognitive neuroscience from the University of Sydney, Australia.

Talks About
#MedicalAffairs #speaker

Preferred Locations
#UnitedStates